1-Methyl-1,2,3,4-tetrahydroisoquinoline enhances the anticonvulsant action of carbamazepine and valproate in the mouse maximal electroshock seizure model

Neuropharmacology

Volumn 50, Issue 2, 2006, Pages 133-142

  Luszczki, Jarogniew J ^a   Antkiewicz Michaluk, Lucyna ^b   Czuczwar, Stanislaw J ^a,c  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

^c INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

1 Methyl 1,2,3,4 tetrahydroisoquinoline; Acute neurotoxic effect; Carbamazepine; Maximal electroshock; Pharmacodynamic interaction; Phenobarbital; Phenytoin; Protective index; Valproate

Indexed keywords

1 METHYL 1,2,3,4 TETRAHYDROISOQUINOLINE; CARBAMAZEPINE; ISOQUINOLINE DERIVATIVE; PHENOBARBITAL; PHENYTOIN; UNCLASSIFIED DRUG; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CONVULSION; DOSE RESPONSE; DRUG ACTIVITY; DRUG POTENTIATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE THRESHOLD; TOXICITY TESTING;

ANIMALS; ANTICONVULSANTS; CARBAMAZEPINE; DOPAMINE ANTAGONISTS; DYSKINESIA, DRUG-INDUCED; ELECTROSHOCK; MALE; MICE; NEUROTOXICITY SYNDROMES; PHENYTOIN; TETRAHYDROISOQUINOLINES; VALPROIC ACID;

EID: 30744441862     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2005.07.016     Document Type: Article

References (72)

1. K. Abe, K. Taguchi, T. Wasai, J. Ren, I. Utsunomiya, T. Shinohara, T. Miyatake, and T. Sano Stereoselective effect of (R)- and (S)-1-methyl-1,2,3,4- tetrahydroisoquinolines on a mouse model of Parkinson's disease Brain Research Bulletin 56 2001 55 60
2. E. Absi, J. Parrado, A. Ayala, and A. Machado Decrease of 1-methyl-1,2,3,4-tetrahydroisoquinoline synthesizing enzyme activity in the brain areas of aged rat Brain Research 955 2002 161 163
3. L. Antkiewicz-Michaluk, B. Karolewicz, I. Romanska, J. Michaluk, A.J. Bojarski, and J. Vetulani 1-Methyl-1,2,3,4-tetrahydroisoquinoline protects against rotenone-induced mortality and biochemical changes in rat brain European Journal of Pharmacology 466 2003 263 269
4. L. Antkiewicz-Michaluk, J. Michaluk, M. Mokrosz, I. Romanska, E. Lorenc-Koci, S. Ohta, and J. Vetulani Different action on dopamine catabolic pathways of two endogenous 1,2,3,4-tetrahydroisoquinolines with similar antidopaminergic properties Journal of Neurochemistry 78 2001 100 108
5. L. Antkiewicz-Michaluk, J. Wardas, J. Michaluk, I. Romaska, A. Bojarski, and J. Vetulani Protective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline against dopaminergic neurodegeneration in the extrapyramidal structures produced by intracerebral injection of rotenone International Journal of Neuropsychopharmacology 7 2004 155 163
6. J.R. Boissier, J. Tardy, and J.C. Diverres Une nouvelle methode simple pour explorer l'action «tranquilisante»: le test de la cheminee Medicina Experimentalis (Basel) 3 1960 81 84
7. Z. Cai, and P.P. McCaslin Amitriptyline, desipramine, cyproheptadine and carbamazepine, in concentrations used therapeutically, reduce kainate- and N-methyl-d-aspartate-induced intracellular Ca2+ levels in neuronal culture European Journal of Pharmacology 219 1992 53 57
8. A.G. Chapman, M.J. Croucher, and B.S. Meldrum Anticonvulsant activity of intracerebroventricularly administered valproate and valproate analogues. A dose-dependent correlation with changes in brain aspartate and GABA levels in DBA/2 mice Biochemical Pharmacology 33 1984 1459 1463
9. S.J. Czuczwar, H.H. Frey, and W. Löscher Antagonism of N-methyl-d,l-aspartic acid-induced convulsions by antiepileptic drugs and other agents European Journal of Pharmacology 108 1985 273 280
10. A.V. Delgado-Escueta, and M.P. Horan Brain synaptosomes in epilepsy: organization of ionic channels and the Na+-K+ pump Advances in Neurology 27 1980 85 126
11. R.J. DeLorenzo A molecular approach to the calcium signal in brain: relationship to synaptic modulation and seizure discharge Advances in Neurology 44 1986 435 464
12. R.J. DeLorenzo, and D.A. Sun Phenytoin and other hydantoins. Mechanisms of action R.H. Levy R.H. Mattson B.S. Meldrum E. Perucca Antiepileptic Drugs fifth ed. 2002 Lippincott Williams & Wilkins Philadelphia 551 565
13. T.V. Dunwiddie, and T. Worth Sedative and anticonvulsant effects of adenosine analogs in mouse and rat Journal of Pharmacology and Experimental Therapeutics 220 1982 70 76
14. G. Ferreri, A. Chimirri, E. Russo, R. Gitto, P. Gareri, A. De Sarro, and G. De Sarro Comparative anticonvulsant activity of N-acetyl-1-aryl-6,7- dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives in rodents Pharmacology Biochemistry and Behavior 77 2004 85 94
15. A. Frandsen, B. Quistorff, and A. Schousboe Phenobarbital protects cerebral cortex neurones against toxicity induced by kainate but not by other excitatory amino acids Neuroscience Letters 111 1990 233 238
16. Y. Fujiwara, M. Sato, and S. Otsuki Interaction of carbamazepine and other drugs with adenosine (A1 and A2) receptors Psychopharmacology (Berlin) 90 1986 332 335
17. R. Gitto, M.L. Barreca, L. De Luca, G. De Sarro, G. Ferreri, S. Quartarone, E. Russo, A. Constanti, and A. Chimirri Discovery of a novel and highly potent noncompetitive AMPA receptor antagonist Journal of Medicinal Chemistry 46 2003 197 200
18. K.A. Grant, L.D. Snell, M.A. Rogawski, A. Thurkauf, and B. Tabakoff Comparison of the effects of the uncompetitive N-methyl-d-aspartate antagonist (+-)-5-aminocarbonyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine (ADCI) with its structural analogs dizocilpine (MK-801) and carbamazepine on ethanol withdrawal seizures Journal of Pharmacology and Experimental Therapeutics 260 1992 1017 1022
19. J.P. Hodgkiss, H.J. Sherriffs, D.A. Cottrell, K. Shirakawa, J.S. Kelly, A. Kuno, M. Ohkubo, S.P. Butcher, and H.J. Olverman Neurochemical and electrophysiological studies on FR115427, a novel non-competitive NMDA receptor antagonist European Journal of Pharmacology 240 1993 219 227
20. C.J. Hough, R.P. Irwin, X.M. Gao, M.A. Rogawski, and D.M. Chuang Carbamazepine inhibition of N-methyl-d-aspartate-evoked calcium influx in rat cerebellar granule cells Journal of Pharmacology and Experimental Therapeutics 276 1996 143 149
21. K.M. Kelly, R.A. Gross, and R.L. Macdonald Valproic acid selectively reduces the low-threshold (T) calcium current in rat nodose neurons Neuroscience Letters 116 1990 233 238
22. G.Y. Ko, L.M. Brown-Croyts, and T.J. Teyler The effects of anticonvulsant drugs on NMDA-EPSP, AMPA-EPSP, and GABA-IPSP in the rat hippocampus Brain Research Bulletin 42 1997 297 302
23. Y. Kotake, R. Taguchi, K. Okuda, Y. Sekiya, Y. Tasaki, M. Hirobe, and S. Ohta Neuroprotective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline on cultured rat mesencephalic neurons in the presence or absence of various neurotoxins Brain Research 1033 2005 143 150
24. Y. Kotake, Y. Tasaki, Y. Makino, S. Ohta, and M. Hirobe 1-Benzyl-1,2,3,4-tetrahydroisoquinoline as a parkinsonism-inducing agent: a novel endogenous amine in mouse brain and parkinsonian CSF Journal of Neurochemistry 65 1995 2633 2638
25. Y. Kotake, M. Yoshida, M. Ogawa, Y. Tasaki, M. Hirobe, and S. Ohta Chronic administration of 1-benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous amine in the brain, induces parkinsonism in a primate Neuroscience Letters 217 1996 69 71
26. G. Künig, B. Niedermeyer, J. Deckert, W. Gsell, G. Ransmayr, and P. Riederer Inhibition of [3H]alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid [AMPA] binding by the anticonvulsant valproate in clinically relevant concentrations: an autoradiographic investigation in human hippocampus Epilepsy Research 31 1998 153 157
27. H. Lampe, and H. Bigalke Carbamazepine blocks NMDA-activated currents in cultured spinal cord neurons Neuroreport 1 1990 26 28
28. J.M. Lancaster, and J.A. Davies Carbamazepine inhibits NMDA-induced depolarizations in cortical wedges prepared from DBA/2 mice Experientia 48 1992 751 753
29. O.M. Larsson, L. Gram, I. Schousboe, and A. Schousboe Differential effect of gamma-vinyl GABA and valproate on GABA-transaminase from cultured neurones and astrocytes Neuropharmacology 25 1986 617 625
30. J.T. Litchfield, and F. Wilcoxon A simplified method of evaluating dose-effect experiments Journal of Pharmacology and Experimental Therapeutics 96 1949 99 113
31. W. Löscher Comparative study of the inhibition of GABA aminotransferase by different anticonvulsant drugs Archives Internationales de Pharmacodynamie et de Therapie 43 1980 48 55
32. W. Löscher Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy CNS Drugs 16 2002 669 694
33. W. Löscher, and B. Nolting The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. IV. Protective indices Epilepsy Research 9 1991 1 10
34. W. Löscher, C.P. Fassbender, and B. Nolting The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models Epilepsy Research 8 1991 79 94
35. A.S. Luder, J.K. Parks, F. Frerman, and W.D. Parker Jr. Inactivation of beef brain alpha-ketoglutarate dehydrogenase complex by valproic acid and valproic acid metabolites. Possible mechanism of anticonvulsant and toxic actions Journal of Clinical Investigations 86 1990 1574 1581
36. J.J. Luszczki, and S.J. Czuczwar Isobolographic and subthreshold methods in the detection of interactions between oxcarbazepine and conventional antiepileptics - a comparative study Epilepsy Research 56 2003 27 42
37. J.J. Luszczki, and S.J. Czuczwar Preclinical profile of combinations of some second-generation antiepileptic drugs: an isobolographic analysis Epilepsia 45 2004 895 907
38. J.J. Luszczki, K.K. Borowicz, M. Swiader, and S.J. Czuczwar Interactions between oxcarbazepine and conventional antiepileptic drugs in the maximal electroshock test in mice: an isobolographic analysis Epilepsia 44 2003 489 499
39. R.L. Macdonald Carbamazepine. Mechanisms of action R.H. Levy R.H. Mattson B.S. Meldrum E. Perucca Antiepileptic Drugs fifth ed. 2002 Lippincott Williams & Wilkins Philadelphia 227 235
40. R.L. Macdonald, and K.M. Kelly Antiepileptic drug mechanisms of action Epilepsia 36 Suppl. 2 1995 S2 S12
41. R.L. Macdonald, C.J. Rogers, and R.E. Twyman Barbiturate regulation of kinetic properties of the GABAA receptor channel of mouse spinal neurones in culture Journal of Physiology 417 1989 483 500
42. P.J. Marangos, R.M. Post, J. Patel, K. Zander, A. Parma, and S. Weiss Specific and potent interactions of carbamazepine with brain adenosine receptors European Journal of Pharmacology 93 1983 175 182
43. K. Matsubara, T. Gonda, H. Sawada, T. Uezono, Y. Kobayashi, T. Kawamura, K. Ohtaki, K. Kimura, and A. Akaike Endogenously occurring beta-carboline induces parkinsonism in nonprimate animals: a possible causative protoxin in idiopathic Parkinson's disease Journal of Neurochemistry 70 1998 727 735
44. M.J. McLean, and R.L. Macdonald Sodium valproate, but not ethosuximide, produces use- and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture Journal of Pharmacology and Experimental Therapeutics 237 1986 1001 1011
45. Z. Miljkovic, and J.F. MacDonald Voltage-dependent block of excitatory amino acid currents by pentobarbital Brain Research 376 1986 396 399
46. H. Nakanishi, K. Katsuta, Y. Ueda, Y. Takasugi, A. Kuno, M. Ohkubo, K. Ogita, Y. Yoneda, K. Shirakawa, and K. Yoshida Behavioral studies on FR115427, a novel selective N-methyl-d-aspartate antagonist Psychopharmacology 117 1995 172 177
47. H. Nau, and W. Löscher Valproic acid: brain and plasma levels of the drug and its metabolites, anticonvulsant effects and gamma-aminobutyric acid (GABA) metabolism in the mouse Journal of Pharmacology and Experimental Therapeutics 220 1982 654 659
48. J. Parrado, E. Absi, A. Ayala, A. Castano, J. Cano, and A. Machado The endogenous amine 1-methyl-1,2,3,4-tetrahydroisoquinoline prevents the inhibition of complex I of the respiratory chain produced by MPP(+) Journal of Neurochemistry 75 2000 65 71
49. A. Patsenka, K. Golembiowska, E. Zieminska, E. Salinska, J. Lazarewicz, A. Wasik, J. Michaluk, and L. Antkiewicz-Michaluk Neuroprotective effects of 1-methyl-1,2,3,4-tetrahydroisoquinoline: in vitro and in vivo studies in rats Polish Journal of Pharmacology 56 Suppl. 2004 179 (abstract)
50. N.I. Phillips, and L.J. Fowler The effects of sodium valproate on gamma-aminobutyrate metabolism and behaviour in naive and ethanolamine-O- sulphate pretreated rats and mice Biochemical Pharmacology 31 1982 2257 2261
51. D. Rampe, J. Ferrante, and D.J. Triggle The actions of diazepam and diphenylhydantoin on fast and slow Ca2+ uptake processes in guinea pig cerebral cortex synaptosomes Canadian Journal of Physiology and Pharmacology 65 1987 538 543
52. J.M. Rho, S.D. Donevan, and M.A. Rogawski Direct activation of GABAA receptors by barbiturates in cultured rat hippocampal neurons Journal of Physiology 497 Pt 2 1996 509 522
53. M.A. Rogawski, A. Thurkauf, S. Yamaguchi, K.C. Rice, A.E. Jacobson, and M.V. Mattson Anticonvulsant activities of 1-phenylcyclohexylamine and its conformationally restricted analog 1,1-pentamethylenetetrahydroisoquinoline Journal of Pharmacology and Experimental Therapeutics 249 1989 708 712
54. M.A. Rogawski, and R.J. Porter Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds Pharmacological Review 42 1990 223 286
55. T.B. Schumacher, H. Beck, C. Steinhauser, J. Schramm, and C.E. Elger Effects of phenytoin, carbamazepine, and gabapentin on calcium channels in hippocampal granule cells from patients with temporal lobe epilepsy Epilepsia 39 1998 355 363
56. H.J. Sherriffs, K. Shirakawa, J.S. Kelly, H.J. Olverman, A. Kuno, M. Okubo, and S.P. Butcher Characterisation of the binding of [3H]FR115427, a novel non-competitive NMDA receptor antagonist, to rat brain membranes European Journal of Pharmacology 247 1993 319 324
57. J.H. Skerritt, L.P. Davies, and G.A. Johnston Interactions of the anticonvulsant carbamazepine with adenosine receptors. 1. Neurochemical studies Epilepsia 24 1983 634 642
58. K.G. Steppuhn, and L. Turski Modulation of the seizure threshold for excitatory amino acids in mice by antiepileptic drugs and chemoconvulsants Journal of Pharmacology and Experimental Therapeutics 265 1993 1063 1070
59. Y. Tasaki, Y. Makino, S. Ohta, and M. Hirobe 1-Methyl-1,2,3,4- tetrahydroisoquinoline, decreasing in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-treated mouse, prevents parkinsonism-like behavior abnormalities Journal of Neurochemistry 57 1991 1940 1943
60. K.F. Tipton, and T.P. Singer Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds Journal of Neurochemistry 61 1993 1191 1206
61. S.M. Todorovic, and C.J. Lingle Pharmacological properties of T-type Ca2+ current in adult rat sensory neurons: effects of anticonvulsant and anesthetic agents Journal of Neurophysiology 79 1998 240 252
62. S.M. Todorovic, E. Perez-Reyes, and C.J. Lingle Anticonvulsants but not general anesthetics have differential blocking effects on different T-type current variants Molecular Pharmacology 58 2000 98 108
63. L. Turski, W. Niemann, and D.N. Stephens Differential effects of antiepileptic drugs and beta-carbolines on seizures induced by excitatory amino acids Neuroscience 39 1990 799 807
64. R.E. Twyman, C.J. Rogers, and R.L. Macdonald Differential regulation of gamma-aminobutyric acid receptor channels by diazepam and phenobarbital Annals of Neurology 25 1989 213 220
65. Y. Ueda, H. Nakanishi, and K. Yoshida Neurotrophic effect of isoquinoline derivatives in primary cortical culture Life Sciences 65 1999 1477 1484
66. J. Vetulani, L. Antkiewicz-Michaluk, I. Nalepa, and M. Sansone A possible physiological role for cerebral tetrahydroisoquinolines Neurotoxicity Research 5 2003 147 155
67. A. Wasik, A. Patsenka, and L. Antkiewicz-Michaluk An endogenous compound 1-methyl-1,2,3,4-tetrahydroisoquinoline prevents the morphine addiction in rat: the view on neurochemical mechanism of action European Neuropsychopharmacology 15 Suppl. 1 2005 S22 S23 (abstract)
68. R.L. Weir, W. Padgett, J.W. Daly, and S.M. Anderson Interaction of anticonvulsant drugs with adenosine receptors in the central nervous system Epilepsia 25 1984 492 498
69. T. Yamakawa, Y. Kotake, M. Fujitani, H. Shintani, Y. Makino, and S. Ohta Regional distribution of parkinsonism-preventing endogenous tetrahydroisoquinoline derivatives and an endogenous parkinsonism-preventing substance-synthesizing enzyme in monkey brain Neuroscience Letters 276 1999 68 70
70. T. Yamakawa, and S. Ohta Isolation of 1-methyl-1,2,3,4- tetrahydroisoquinoline-synthesizing enzyme from rat brain: a possible Parkinson's disease-preventing enzyme Biochemical and Biophysical Research Communications 236 1997 676 681
71. T. Yamakawa, and S. Ohta Biosynthesis of a parkinsonism-preventing substance, 1-methyl-1,2,3,4-tetrahydroisoquinoline, is inhibited by parkinsonism-inducing compounds in rat brain mitochondrial fraction Neuroscience Letters 259 1999 157 160
72. M.L. Zeise, S. Kasparow, and W. Zieglgansberger Valproate suppresses N-methyl-d-aspartate-evoked, transient depolarizations in the rat neocortex in vitro Brain Research 544 1991 345 348